The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...
A recent Signal Transduction and Targeted Therapy study summarized the structure of inflammasomes and their role in diseases. This study also explored the therapeutic potential of inflammasomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback